The North America Infection Surveillance Solutions Market would witness market growth of 11.7% CAGR during the forecast period (2023-2029).
Software analysis tools are being used by hospitals & other healthcare facilities as a solution by examining several criteria and incorporating them for the implementation & estimation of public health practices to control the incidence of connected healthcare infections, infection surveillance analytics aid in the organization and interpretation of health data.
In addition, governments are anticipated to adopt these solutions due to the solutions' high degree of use and ability to support the development of the healthcare ecosystem. Information gathering, analysis, and interpretation about patients with various infections are made easier by infection surveillance systems for healthcare professionals. By disseminating information, they alert hospitals to hospital internet protocol and assist nurses & doctors in providing patient care.
They also assist in identifying antibiotic-resistant organisms (AROs), reduce the risk of respiratory tract infections, and guard against pneumonia from ventilators, surgical wounds, urinary tract infections, and bloodstream infusions. Additional features include precise employee health information, surgical databases, real-time access to medical records, and shifts in microbiological pathogens. Infection surveillance technologies also help spot epidemics.
One of the world's greatest marketplaces for medical technology research in North America. The region's massive market is largely due to expanding R&D in the medical sciences. Particularly in the U.S., Health and Human Services (HHS), overseen by the cabinet-level agency of the U.S. federal government, is especially liberal in financing & maintaining technological advancements in medical science. In addition, the U.S. Department of Health and Human Services (HHS) has made preventing and reducing healthcare-related diseases a primary focus. These factors are impacting the expansion of hospital technology, which are expected to boost the market for infection surveillance solutions in the North America region.
The US market dominated the North America Infection Surveillance Solutions Market by Country in 2022; thereby, achieving a market value of $381.7 Million by 2029. The Canada market is experiencing a CAGR of 13.8% during (2023 - 2029). Additionally, The Mexico market would exhibit a CAGR of 13.5% during (2023 - 2029).
Based on Product & Services, the market is segmented into Software (On-premise and Web-based Software) and Services. Based on End User, the market is segmented into Hospitals, Long-term Care Facilities and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Infection Surveillance Solutions Market is Projected to reach USD 1.3 Billion by 2029, at a CAGR of 12.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
By Product & Services
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
